MilliporeSigma
Search Within
Document Type

624-89-5

Applied Filters:
Keyword:'624-89-5'
Showing 1-24 of 24 results for "624-89-5" within Technical Documents
Application Note - Detection and quantification of leached Protein A from Eshmuno A resin using Cygnus F400 Protein A ELISA kit
0.126 0.734 0.71 94% 80.6 0.122 0.687 Post- AEX 1 5 0.269 0.277 5.025 4.85 91% 89% 1.4 1.7 2.2 0.284 4.675 2 5 0.404 0.410 4.099 4.21 76% 2.0 0.415 4.312 1 10 0.122
XP725 Antibody Number-Lot Number 071M4826
76 1.2 5 6 7 8 29 30 31 32 53 54 55 56 77 78 79 80 1.3 9 10 11 12 33 34 35 36 57 58 59 60 81 82 83 84 1.4 13 14 15 16 37 38 39
Product Information Sheet - 11756281001
Vol. 1, No. 2, 125–131. 4 Snyder,S. (1992) Science 257, 494–496. 5 Edelman, G.M. & Gally, J.A. (1992) Proc. Natl. Acad. Sci. USA 89, 11651-11652. 6 Marletta, M.A. (1993) J. Biol. Chem. 268, 12231-12234
Anti-NeuN, clone A60 - Data Sheet
2) J. Histochem. Cytochem. (1996) 44:1167-1171. 3) Nature (1996) 383:624-627. 4) J. Neuroscience (1997) 17:5820-5829. 5) J. Neuroscience (1997) 17:7415-7424. 6) J. Neuroscience (1998) 18:3206
SpheriCal MALDI Calibration Guide Aqua
/z 0 250 500 750 1000 1250 1500 In te n s . [a .u .] 621 622 623 624 625 626 627 628 629 m/z 0 1000 2000
Fast GC-A Practical Guide for Increasing Sample Throughput without Sacrificing Quality
Sacrificing Resolution Environmental Applications Figure 14. US EPA Method 624 Volatiles on SPB-624 1 2 3 4 5 6 8 9 107 11,12 13 14,15 16 17 18
Corticotropin-Releasing Factor Receptor Antagonists- Potential Novel Therapies for Human Disease
Kasckow, J.W., et al., Peptides, 22, 845-851 (2001). 98. Bremner, J.D., et al., Am. J. Psychiatry, 154, 624-629 (1997). 99. Griebel, G., et al., Psychopharmacology (Berl) , 138, 55-66 (1998). 100. Gorman, J.
Inhibitor Sourcebook 3rd Edition
Ki = 480 nM). 1 mg 5 mg InSolution™H-89, Dihydrochloride 371962 {N-[2-((p-Bromocinnamyl)amino)ethyl]-5-isoquinolinesulfonamide, 2hCl} A 10 mM (1 mg/193 µl) solution of H-89, Dihydrochloride (Cat.
Amidine-Based Catalysts (ABCs)- Design Development and Applications
20 oC 2. NuH (2.0–15.0 equiv) 1. 30a (20 mol %) HOBt (20 mol %) 21 examples, 33–89% dr = 88:12 to >95:5 85 to >99% ee 30 Amidine-Based Catalysts
ExPlore with Confidence: Prestige Antibodies Breast Cancer Research
is associated with an improved prog- nosis in colorectal cancer. Proteomics Clin Appl 2011 Dec;5(11-12):624-35 133. Ehlén A et al. Expression of the RNA-binding protein RBM3 is associated with a favourable
Aldrichimica Acta Volume 50 Number 1
THF 0 oC, 0.5 h Me OH 8 (1 mol %) THF, rt, 5 hMe7 8 OH8 Me + oleyl alcohol 90 92; 68%, 88% Z91 OAc8 Me (Z,E)-9,12-TDDA pheromone 89% Ac2O, Pyr Me Cl
Halal Certificate
FG W246000 A11573 HC-23SI3O19 623. ETHYL TRANS-2-BUTENOATE 96%, FG W348600 B20507 HC-23SIZQ89 624. ETHYL TRANS-2-DECENOATE 95%, FG (STABILISED) W364118 A17436 HC-23SI8763 625. ETHYL TRANS-3-HEXENOATE
Halal Certificate
FG W246000 A11573 HC-22SI6H40 623. ETHYL TRANS-2-BUTENOATE 96%, FG W348600 B20507 HC-22SIAJ11 624. ETHYL TRANS-2-DECENOATE 95%, FG (STABILISED) W364118 A17436 HC-22SIKR84 625. ETHYL TRANS-3-HEXENOATE
Brochure: Chromolith® Monolithic Silica HPLC Columns for small and large molecule separation
area Pressure (bar) 0.19 mL/min 11% 89% 5 bar 0.38 mL/min 11% 89% 10 bar 0.57 mL/min 11% 89% 15 bar 0.76 mL/min 11% 89% 19 bar 0.95 mL/min 11% 89% 24 bar Monolithic
Chrombook 2015 - The world of chromatography in your hands
Sample preparation 5 20 25 30 35 40 450 0 5 10 15 20 25 30 10 15 50 54 89 Retention time [min] Intensity [mV] 210 nm 5
XP725 Antibody List Lot 129K4831
NA NA M 576 Anti Cy3+Cy5 C0992 NA NA M 600 Anti Cy3+Cy5 C0992 NA NA M 613 PSF P2860 NA NA M y y n/d 624 Anti Cy3+Cy5 C0992 NA NA M 648 Anti Cy3+Cy5 C0992 NA NA M 653 S-Nitrosocysteine N5411 NA NA P
XP725 Antibody List Lot 129K4830
NA NA M 576 Anti Cy3+Cy5 C0992 NA NA M 600 Anti Cy3+Cy5 C0992 NA NA M 613 PSF P2860 NA NA M y y n/d 624 Anti Cy3+Cy5 C0992 NA NA M 648 Anti Cy3+Cy5 C0992 NA NA M 653 S-Nitrosocysteine N5411 NA NA P
XP725 Antibody List Lot 089K4791
NA NA M 576 Anti Cy3+Cy5 C0992 NA NA M 600 Anti Cy3+Cy5 C0992 NA NA M 613 PSF P2860 NA NA M y y n/d 624 Anti Cy3+Cy5 C0992 NA NA M 648 Anti Cy3+Cy5 C0992 NA NA M 653 S-Nitrosocysteine N5411 NA NA P
XP725 Worksheet for Lot Number 071M4826
A4355 85 1 2 5 5 ASPP2 A4480 86 1 2 5 6 ASPP2 A4480 87 1 2 5 7 ATF1 A7833 88 1 2 5 8 ATF1 A7833 89 1 2 6 1 ATF2 A4086 90 1 2 6 2 ATF2 A4086 91 1 2 6
List of Antibodies
) P6989 P y n/d n/d 621 AP2 alpha P6739 M y n/d n/d 622 Negative Control NA 623 Rab5 R7904 M y y y 624 Anti Cy3+Cy5 C0992 M NA NA NA 625 Rab 7 R8779 M y y y 626 Rab9 R5404 M y
3D BIOPRINTING: Printing a Brighter Future
F.; Israel, E.; Kelly, D. P.; Chou, C.-Y.; Koch, K.; Asfari, B.; Hecht, S. Nature 2020, 588, 620–624. (29) Kelly, B. E.; Bhattacharya, I.; Heidari, H.; Shusteff, M.; Spadaccini, C. M.; Taylor, H.
3D BIOPRINTING: Printing a Brighter Future
F.; Israel, E.; Kelly, D. P.; Chou, C.-Y.; Koch, K.; Asfari, B.; Hecht, S. Nature 2020, 588, 620–624. (29) Kelly, B. E.; Bhattacharya, I.; Heidari, H.; Shusteff, M.; Spadaccini, C. M.; Taylor, H.
XP725 Antibody List 013M4793
Control NA 623 Rab5 R7904 5868, 64633, 271457 RAB5A,Rab5a NP_004153.2,NP_073183.1,NP_080163.1 M y y y 624 Anti Cy3+Cy5 C0992 625 Rab 7 R8779 29448, 19349, 7879 Rab7,RAB7 NP_076440.1,NP_033031.2,NP_004628.4
XP725 Antibody List
Control 623 Rab5 R7904 5868, 64633, 271457 RAB5A,Rab5a NP_004153.2,NP_073183.1,NP_080163.1 M y y y 624 Anti Cy3+Cy5 625 Rab 7 R8779 29448, 19349, 7879 Rab7,RAB7 NP_076440.1,NP_033031.2,NP_004628.4 M y y